AMRZ · Amrize Ltd - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Price · AMRZ
Income Statement
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q4 '22 |
|---|---|---|---|---|---|
| Revenue | $2.18B | - | $3.67B | $3.24B | - |
| Cost of Revenue | $1.86B | - | $2.59B | $2.25B | - |
| Gross Profit | $211.00M | - | $1.04B | $979.00M | - |
| R&D | - | - | - | - | - |
| SG&A | $239.00M | - | $312.00M | $299.00M | - |
| Total Operating Expenses | - | - | - | - | - |
| D&A | $181.00M | - | $192.00M | $182.00M | - |
| Operating Income | ($76.00M) | - | $778.00M | $754.00M | - |
| Interest Expense | $11.00M | - | $79.00M | $54.00M | - |
| Income Tax | ($27.00M) | - | $150.00M | $122.00M | - |
| Net Income | ($116.00M) | - | $545.00M | $474.00M | - |
| EPS - Basic | ($0.16) | - | $0.99 | $0.78 | - |
| EPS - Diluted | ($0.16) | - | $1.00 | $0.86 | - |
Balance Sheet
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q4 '22 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1.10B | $1.92B | $826.00M | $601.00M | $351.00M |
| Accounts Receivable | - | - | - | - | - |
| Inventory | $1.57B | $1.55B | $1.51B | $1.45B | - |
| Accounts Payable | $1.02B | - | - | - | - |
| Current Assets | $4.28B | $4.68B | $4.57B | $4.78B | - |
| Total Assets | $24.27B | $24.25B | $24.04B | $23.78B | - |
| Current Liabilities | $3.05B | $2.86B | $3.15B | $2.55B | - |
| Long-term Debt | $4.94B | - | - | - | - |
| Total Liabilities | $11.18B | $10.99B | $11.14B | $13.89B | - |
| Stockholders' Equity | $13.09B | $13.26B | $12.90B | $12.43B | $8.21B |
| Retained Earnings | $785.00M | $902.00M | $601.00M | $0 | - |
Cash Flow
| Line item | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q4 '22 |
|---|---|---|---|---|---|
| Operating Cash Flow | ($856.00M) | - | - | - | - |
| Investing Cash Flow | ($60.00M) | - | - | - | - |
| Financing Cash Flow | $743.00M | - | - | - | - |
| CapEx | $211.00M | - | - | - | - |
| Free Cash Flow | ($1.07B) | - | - | - | - |
Ratios
| Metric | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q4 '22 |
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 9.7% | - | 28.4% | 30.2% | - |
| Operating margin | -3.5% | - | 21.2% | 23.3% | - |
| EBITDA margin | 4.8% | - | 26.4% | 28.9% | - |
| Net margin | -5.3% | - | 14.8% | 14.6% | - |
| Free cash flow margin | -49.0% | - | - | - | - |
| FCF / Net income | 9.20 | - | - | - | - |
| R&D / Revenue | - | - | - | - | - |
| SG&A / Revenue | 11.0% | - | 8.5% | 9.2% | - |
| Effective tax rate | - | - | 21.6% | 20.5% | - |
| Return on assets | -0.5% | - | 2.3% | 2.0% | - |
| Return on equity | -0.9% | - | 4.2% | 3.8% | - |
| Return on invested capital | -0.3% | - | - | - | - |
| Liquidity | |||||
| Current ratio | 1.40 | 1.64 | 1.45 | 1.87 | - |
| Quick ratio | 0.89 | 1.10 | 0.97 | 1.31 | - |
| Cash ratio | 0.36 | 0.67 | 0.26 | 0.24 | - |
| Leverage | |||||
| Debt / Equity | 0.38 | - | - | - | - |
| Debt / Assets | 0.20 | - | - | - | - |
| Debt / EBITDA | 47.01 | - | - | - | - |
| Interest coverage | -6.9x | - | 9.8x | 14.0x | - |
| Equity multiplier | 1.85 | 1.83 | 1.86 | 1.91 | - |
| Liabilities / Assets | 0.46 | 0.45 | 0.46 | 0.58 | - |
| Efficiency | |||||
| Asset turnover | 0.09 | - | 0.15 | 0.14 | - |
| Inventory turnover | 1.19 | - | 1.71 | 1.55 | - |
| Days sales outstanding | - | - | - | - | - |
| Days inventory outstanding | 308d | - | 213d | 235d | - |
| Days payable outstanding | 200d | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - |
| Valuation | |||||
| P / E | - | - | 48.5x | 57.6x | - |
| P / B | 2.4x | - | 2.1x | 2.2x | - |
| P / S | 14.2x | - | 7.3x | 8.5x | - |
| EV / EBITDA | 331.7x | - | 26.9x | 28.6x | - |
| Growth | |||||
| Revenue growth (YoY) | - | - | - | - | - |
| Revenue CAGR (3y) | - | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - |
| Operating income growth (YoY) | - | - | - | - | - |
| Net income growth (YoY) | - | - | - | - | - |
| EPS growth (YoY) | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - |
| FCF growth (YoY) | - | - | - | - | - |
| FCF CAGR (5y) | - | - | - | - | - |
| Book value growth (YoY) | - | - | - | - | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$11.81B totalBuilding Materials$8.51B · 72.1%
Building Envelope$3.30B · 27.9%
Product / service
$8.51B totalAggregates And Other Construction Materials$4.67B · 54.8%
Cement$4.39B · 51.6%
Interproduct Revenues($540.00M) · -6.3%
Geographic
$24.60B totalUS$9.11B · 37.0%
Central Region$3.62B · 14.7%
Southern Region$3.53B · 14.3%
CA$2.67B · 10.9%
Great Lakes Region$2.42B · 9.9%
Northeastern Region$1.88B · 7.6%
Pacific Region$1.33B · 5.4%
Other Geographical Regions$29.00M · 0.1%
Peer comparison
Same SIC group: Cement, Hydraulic
Comparing Amrize Ltd against the 4 most active filers in the same SIC group.
Dividends
$0.55/share trailing 12 months
| Ex-date | Per share |
|---|---|
| May 12, 2026 | $0.1100 |
| Apr 24, 2026 | $0.4400 |